|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.520 EUR | -.--% |
|
-.--% | - |
| 04-20 | Exprivia SpA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 25-06-08 | Exprivia SpA Reports Earnings Results for the Full Year Ended December 31, 2024 | CI |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.32 | 5.79 | 6.13 | 6.15 | 5.14 | |||||
Return on Total Capital | 8.62 | 9.67 | 10.31 | 10.68 | 10.1 | |||||
Return On Equity % | 14.73 | 14.72 | 14.81 | 18.48 | 18.05 | |||||
Return on Common Equity | 14.79 | 14.73 | 14.81 | 18.44 | 17.83 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 13.73 | 12.93 | 12.07 | 12.42 | 10.38 | |||||
SG&A Margin | 0.16 | 0.16 | 0.23 | 0.28 | - | |||||
EBITDA Margin % | 11.54 | 11.81 | 11.5 | 11.84 | 9.29 | |||||
EBITA Margin % | 10.53 | 11.08 | 10.93 | 10.83 | 6.96 | |||||
EBIT Margin % | 10.12 | 10.75 | 10.69 | 10.61 | 6.96 | |||||
Income From Continuing Operations Margin % | 5.69 | 6.47 | 6.66 | 6.3 | 4.54 | |||||
Net Income Margin % | 5.71 | 6.47 | 6.65 | 6.28 | 4.42 | |||||
Net Avail. For Common Margin % | 5.71 | 6.47 | 6.65 | 6.28 | 4.42 | |||||
Normalized Net Income Margin | 5.3 | 5.83 | 5.71 | 5.44 | 3.91 | |||||
Levered Free Cash Flow Margin | 9.41 | 6.1 | 6.56 | 7.31 | 5.54 | |||||
Unlevered Free Cash Flow Margin | 10.31 | 6.92 | 7.46 | 8.73 | 5.86 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.84 | 0.86 | 0.92 | 0.93 | 1.18 | |||||
Fixed Assets Turnover | 9.62 | 10.37 | 11.68 | 11.85 | 15.73 | |||||
Receivables Turnover (Average Receivables) | 2.36 | 2.3 | 2.41 | 2.38 | 2.85 | |||||
Inventory Turnover (Average Inventory) | 153.23 | 167.45 | 130.91 | 127.7 | 189.81 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.2 | 1.13 | 1.19 | 1.09 | 1.15 | |||||
Quick Ratio | 1.16 | 1.09 | 1.16 | 1.06 | 0.96 | |||||
Operating Cash Flow to Current Liabilities | 0.21 | 0.14 | 0.16 | 0.18 | 0.16 | |||||
Days Sales Outstanding (Average Receivables) | 154.78 | 158.88 | 151.61 | 153.9 | 128.12 | |||||
Days Outstanding Inventory (Average Inventory) | 2.38 | 2.18 | 2.79 | 2.87 | 1.92 | |||||
Average Days Payable Outstanding | 64.2 | 65.58 | 63.85 | 72.62 | 59.72 | |||||
Cash Conversion Cycle (Average Days) | 92.97 | 95.48 | 90.55 | 84.15 | 70.32 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 67.97 | 49.47 | 39.26 | 71.53 | 70.91 | |||||
Total Debt / Total Capital | 40.46 | 33.09 | 28.19 | 41.7 | 41.49 | |||||
LT Debt/Equity | 45.94 | 22.06 | 15.28 | 37.11 | 42.52 | |||||
Long-Term Debt / Total Capital | 27.35 | 14.76 | 10.97 | 21.63 | 24.88 | |||||
Total Liabilities / Total Assets | 64.3 | 60.07 | 57.51 | 67.34 | 72.32 | |||||
EBIT / Interest Expense | 7.07 | 8.2 | 7.4 | 4.66 | 13.51 | |||||
EBITDA / Interest Expense | 8.79 | 9.84 | 8.66 | 5.69 | 18.04 | |||||
(EBITDA - Capex) / Interest Expense | 8.44 | 9.6 | 8.46 | 5.45 | 16.34 | |||||
Total Debt / EBITDA | 2.24 | 1.78 | 1.51 | 1.98 | 2.11 | |||||
Net Debt / EBITDA | 1.39 | 1.03 | 0.56 | 1.35 | 0.95 | |||||
Total Debt / (EBITDA - Capex) | 2.33 | 1.82 | 1.54 | 2.07 | 2.33 | |||||
Net Debt / (EBITDA - Capex) | 1.45 | 1.05 | 0.57 | 1.41 | 1.05 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 8.84 | -0.39 | 10.72 | 7.13 | 58.46 | |||||
Gross Profit, 1 Yr. Growth % | 30.04 | -8.95 | 2.76 | 12.06 | 32.39 | |||||
EBITDA, 1 Yr. Growth % | 20.11 | 2.03 | 7.65 | 8.74 | 24.31 | |||||
EBITA, 1 Yr. Growth % | 18.99 | 4.8 | 9.12 | 9.3 | 1.81 | |||||
EBIT, 1 Yr. Growth % | 20.43 | 5.77 | 10.07 | 9.45 | 3.99 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 17.45 | 13.76 | 14.08 | 10.62 | 14.12 | |||||
Net Income, 1 Yr. Growth % | -93.86 | 13.41 | 13.93 | 10.36 | 11.53 | |||||
Normalized Net Income, 1 Yr. Growth % | 29.67 | 9.3 | 8.48 | 10.13 | 13.93 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 17.23 | 6.61 | 20 | - | - | |||||
Accounts Receivable, 1 Yr. Growth % | 2.93 | 1.93 | 9.37 | 7.55 | 52.33 | |||||
Inventory, 1 Yr. Growth % | -11.47 | -3.08 | 90.58 | -33.22 | 72.46 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -5.32 | -9.03 | 6.39 | 4.82 | 33.24 | |||||
Total Assets, 1 Yr. Growth % | -4.39 | 0.05 | 7.82 | 3.66 | 44.62 | |||||
Tangible Book Value, 1 Yr. Growth % | -105.7 | 1.55K | 139.04 | -187.38 | -420.83 | |||||
Common Equity, 1 Yr. Growth % | 16.11 | 11.89 | 14.71 | 10.58 | 19.59 | |||||
Cash From Operations, 1 Yr. Growth % | -48.21 | -26.74 | 23.15 | 34.65 | 35.51 | |||||
Capital Expenditures, 1 Yr. Growth % | -68.83 | -36.06 | -0.7 | 107.57 | 149.53 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -186.95 | -35.35 | 19.14 | 22.32 | 20.09 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -204.63 | -33.01 | 19.46 | 24.16 | 6.36 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 3.91 | 4.39 | 5.02 | 8.91 | 30.29 | |||||
Gross Profit, 2 Yr. CAGR % | 21.1 | 10.73 | -2.99 | 6.43 | 21.8 | |||||
EBITDA, 2 Yr. CAGR % | 18.51 | 10.98 | 4.88 | 8.96 | 16.27 | |||||
EBITA, 2 Yr. CAGR % | 33.98 | 11.98 | 6.94 | 7.67 | 5.49 | |||||
EBIT, 2 Yr. CAGR % | 31.34 | 13.18 | 7.9 | 8.18 | 6.68 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 59.14 | 15.59 | 13.92 | 7.54 | 12.35 | |||||
Net Income, 2 Yr. CAGR % | -75.74 | -73.61 | 13.67 | 7.34 | 10.94 | |||||
Normalized Net Income, 2 Yr. CAGR % | -63.43 | 19.45 | 8.89 | 5.19 | 12.02 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -61.64 | 11.79 | 13.11 | - | - | |||||
Accounts Receivable, 2 Yr. CAGR % | -37.63 | 2.43 | 5.58 | 8.46 | 28 | |||||
Inventory, 2 Yr. CAGR % | -80.1 | -7.37 | 35.91 | 12.82 | 7.32 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -38.28 | -7.19 | -1.62 | 5.6 | 18.18 | |||||
Total Assets, 2 Yr. CAGR % | -29.67 | -2.2 | 3.86 | 5.82 | 22.44 | |||||
Tangible Book Value, 2 Yr. CAGR % | -94.09 | -3.17 | 527.25 | -61 | 67.44 | |||||
Common Equity, 2 Yr. CAGR % | -15.69 | 13.98 | 13.29 | -4.31 | 15 | |||||
Cash From Operations, 2 Yr. CAGR % | -24.24 | -38.4 | -5.01 | 23.09 | 35.08 | |||||
Capital Expenditures, 2 Yr. CAGR % | -31.73 | -55.36 | -20.25 | 43.57 | 127.59 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -37 | -24.88 | -12.25 | 19.22 | 21.2 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -35.84 | -16.13 | -10.55 | 22.35 | 14.91 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -33.82 | 2.64 | 6.46 | 5.72 | 23.41 | |||||
Gross Profit, 3 Yr. CAGR % | -15.02 | 11.41 | 8.22 | 1.23 | 14.47 | |||||
EBITDA, 3 Yr. CAGR % | -10.37 | 12.93 | 9.91 | 6.66 | 13.86 | |||||
EBITA, 3 Yr. CAGR % | -8.51 | 23.67 | 11.02 | 6.71 | 5.68 | |||||
EBIT, 3 Yr. CAGR % | -5.19 | 22.42 | 12.14 | 7.37 | 6.76 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 131.61 | 42.29 | 15.08 | 9.57 | 9.69 | |||||
Net Income, 3 Yr. CAGR % | 294.22 | -59.43 | -57.03 | 9.33 | 8.72 | |||||
Normalized Net Income, 3 Yr. CAGR % | 59.8 | -47.2 | 15.68 | 6.54 | 8.03 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 273.06 | -46.07 | 14.46 | - | - | |||||
Accounts Receivable, 3 Yr. CAGR % | -29.82 | -26.53 | 4.69 | 6.24 | 21.46 | |||||
Inventory, 3 Yr. CAGR % | -69.73 | -66.26 | 17.82 | 7.25 | 29.96 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -13.32 | -29.76 | -2.87 | 0.48 | 14.11 | |||||
Total Assets, 3 Yr. CAGR % | -32.31 | -20.9 | 1.04 | 3.86 | 17.43 | |||||
Tangible Book Value, 3 Yr. CAGR % | -83.97 | -61.42 | 30.87 | 35.79 | -21.27 | |||||
Common Equity, 3 Yr. CAGR % | 0.74 | -7.35 | 14.22 | 0.81 | 3.07 | |||||
Cash From Operations, 3 Yr. CAGR % | -15.41 | -25.08 | -22.4 | 3.54 | 27.1 | |||||
Capital Expenditures, 3 Yr. CAGR % | -36.75 | -33.2 | -41.69 | 9.7 | 72.62 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -5.1 | -36.38 | -12.4 | -2.78 | 19.51 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -13.8 | -34.83 | -5.64 | 0.09 | 16.77 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 5 | 2.21 | -20.31 | 5.1 | 15.42 | |||||
Gross Profit, 5 Yr. CAGR % | 9.29 | 3.8 | -9.77 | 9.52 | 13.09 | |||||
EBITDA, 5 Yr. CAGR % | 9.35 | 13.26 | -4.46 | 11.36 | 12.73 | |||||
EBITA, 5 Yr. CAGR % | 10.45 | 28.17 | -2.51 | 17.01 | 8.16 | |||||
EBIT, 5 Yr. CAGR % | 15.55 | 27.39 | -0.04 | 16.51 | 9.28 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 29 | 196.89 | 74.38 | 27.21 | 12.01 | |||||
Net Income, 5 Yr. CAGR % | 29.24 | 235.83 | 139.72 | -40.13 | -38.29 | |||||
Normalized Net Income, 5 Yr. CAGR % | 20.47 | 54.45 | 37.26 | -30.44 | 12.65 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 30.02 | 228.35 | 131.45 | - | - | |||||
Accounts Receivable, 5 Yr. CAGR % | 0.22 | -16.2 | -17.36 | -14.15 | 13.46 | |||||
Inventory, 5 Yr. CAGR % | -1.56 | -53.28 | -44.8 | -45.32 | 13.5 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 2.35 | -10.29 | -8.82 | -17.32 | 5.06 | |||||
Total Assets, 5 Yr. CAGR % | 0.09 | -20.32 | -19.67 | -11.14 | 9.15 | |||||
Tangible Book Value, 5 Yr. CAGR % | 41.04 | -41.18 | -30.51 | -61.25 | -14.47 | |||||
Common Equity, 5 Yr. CAGR % | -0.23 | 2.13 | 5.59 | -6.15 | 7.3 | |||||
Cash From Operations, 5 Yr. CAGR % | 8.95 | 8.14 | -11.39 | -8.62 | -4.87 | |||||
Capital Expenditures, 5 Yr. CAGR % | -25.8 | -3.99 | -30.6 | -9.25 | 0.53 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 22.88 | 72.73 | -7.96 | -18.21 | -0.75 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 33.84 | 55.38 | -12.45 | -16.16 | 2.29 |
- Stock Market
- Stocks
- XPR Stock
- Financials EXPRIVIA
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















